Virtual Medicinal Product (VMP) - Lenacapavir 463.5mg/1.5ml solution for injection vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Lenacapavir 463.5mg/1.5ml solution for injection vials | Start Date 19-05-2025 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.5
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- J05AX31
- BNF Codes
-
- BNF code 05030100
| Code | Start Date | End Date |
|---|---|---|
| 45160711000001109 | 19-05-2025 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Lenacapavir sodium | Based on Base Substance | Lenacapavir | 309 mg | 1 ml |
Name
Lenacapavir sodium
Basis of strength description
Based on Base Substance
BOSS
Lenacapavir
Strength and UOM (Nmr)
309.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMLenacapavir
-
VMP(Current) Lenacapavir 463.5mg/1.5ml solution f...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 2 vial |